Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKR 202 in Knee Osteoarthritis Pain
NCT02003118Phase 2Completed
- Sponsor
- Akron Molecules AG
- Start
- Oct 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adefovir dipivoxil in osteoarthritis (OA), sponsored by Akron Molecules AG. Started Oct 2013; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02003118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003118.